Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: A role of histone deacetylase inhibition

FEBS Letters

Volumn 542, Issue 1-3, 2003, Pages 74-78

  Jeong, Mi Ra ^a   Hashimoto, Ryota ^a   Senatorov, Vladimir V ^a   Fujimaki, Koichiro ^a   Ren, Ming ^a   Lee, Min Soo ^b   Chuang, De Maw ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Korea University College of Medicine   (South Korea)

Author keywords

Bipolar mood disorder; Cerebral cortical neuron; Histone deacetylase; Lithium; Neuroprotection; Valproate

Indexed keywords

ANTICONVULSIVE AGENT; CALCEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; NEUROLEPTIC AGENT; TRICHOSTATIN A; VALPROIC ACID; VALPROIC ACID DERIVATIVE;

ACETYLATION; AGING; ANIMAL CELL; ARTICLE; BRAIN CELL; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; ENZYME INHIBITION; MITOCHONDRION; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0038066627     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(03)00350-8     Document Type: Article

References (19)

1. Johannessen C.U. Neurochem. Int. 37:2000;103-110.
2. Tunnicliff G. J. Physiol. Pharmacol. 50:1999;347-365.
3. Manji H.K., Drevets W.C., Charney D.S. Nat. Med. 7:2001;541-547.
4. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. J. Biol. Chem. 276:2001;36734-36741.
5. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., Sleeman J.P., Lo Coco F., Nervi C., Pelicci P.G., Heinzel T. EMBO J. 20:2001;6969-6978.
6. Chang K.T., Min K.T. Aging Res. Rev. 1:2002;313-326.
7. De Sarno P., Li X., Jope R.S. Neuropharmacology. 43:2002;1158-1164.
8. Chuang D.-M., Chen R.W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T., Leeds P. Bipolar Disord. 4:2002;129-136.
9. Drevets W.C., Price J.L., Simpson J.R. Jr., Todd R.D., Reich T., Vannier M., Raichle M.E. Nature. 386:1997;824-827.
10. Hashimoto R., Hough C., Nakazawa T., Yamamoto T., Chuang D.-M. J. Neurochem. 80:2002;589-597.
11. Lin W.W., Wang C.W., Chuang D.-M. J. Neurochem. 678:1997;2577-2586.
12. Williams R.S., Cheng L., Mudge A.W., Harwood A.J. Nature. 417:2002;292-295.
13. Hall A.C., Brennan A., Goold R.G., Cleverley K., Lucas F.R., Gordon-Weeks P.R., Salinas P.C. Mol. Cell. Neurosci. 20:2002;257-270.
14. Lampen A., Siehler S., Ellerbeck U., Gottlicher M., Nau H. Toxicol. Appl. Pharmacol. 160:1999;238-249.
15. Guarente L., Kenyoin C. Nature. 408:2000;255-262.
16. Tissenbaum H.A., Guarente L. Nature. 410:2001;227-230.
17. Ishitani R., Sunaga K., Hirano A., Saunders P., Katsube N., Chuang D.-M. J. Neurochem. 66:1996;928-935.
18. Chen G., Huang L.D., Jiang Y.M., Manji H.K. J Neurochem. 72:1999;1327-1330.
19. Brown C.D., Wang J.F., Chen B., Young L.T. Bipolar Disord. 4:2002;145-151.